Minji Kim
Corporate Officer/Principal presso MINERALYS THERAPEUTICS, INC.
Profilo
Minji Kim is currently the Chief Business Officer at Mineralys Therapeutics, Inc. Prior to this, she worked as the Vice President of Corporate and Business Development at Curis, Inc. and as an Associate in Global Business Development and Licensing at Hoffmann-La Roche, Inc. She holds a Master's in Business Administration from Yale University and a doctorate from Seoul National University.
Posizioni attive di Minji Kim
| Società | Posizione | Inizio |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Corporate Officer/Principal | 04/01/2024 |
Precedenti posizioni note di Minji Kim
| Società | Posizione | Fine |
|---|---|---|
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| CURIS, INC. | Corporate Officer/Principal | - |
Formazione di Minji Kim
| Seoul National University | Doctorate Degree |
| Yale University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CURIS, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Borsa valori
- Insiders
- Minji Kim